89 results
425
CHMA
Chiasma, Inc
5 May 21
Business combination disclosure
5:24pm
the full potential of MYCAPSSA® globally and further develop life-cycle management opportunities to expand the benefits of MYCAPSSA® to other patient … globally and expand the potential benefits of MYCAPSSA® to other patients with unmet needs. The combined business has significant potential
F-1
EX-10.12.1
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
with the Additional Terms and Conditions For Benefits Investigation and Reimbursement Support Services, attached and incorporated herein by reference.
1.3 (I … .
Service Provider and any person performing Services:
6.2 (a)
will not be eligible to participate in or receive any benefits or have any rights
6-K
EX-99.5
AMYT
Amryt Pharma Plc
5 May 21
Agreement and Plan of Merger
5:19pm
and the financial flexibility to realize the full potential of MYCAPSSA® globally and further develop life-cycle management opportunities to expand the benefits … in successfully commercializing MYCAPSSA® globally and expand the potential benefits of MYCAPSSA® to other patients with unmet needs. The combined business
DRS/A
EX-10.12
AMYT
Amryt Pharma Plc
11 May 20
Draft registration statement (amended)
12:00am
with the Additional Terms and Conditions For Benefits Investigation and Reimbursement Support Services, attached and incorporated herein by reference.
1.3 (I … .
Service Provider and any person performing Services:
6.2 (a)
will not be eligible to participate in or receive any benefits or have any rights
6-K
EX-99.1
AMYT
Amryt Pharma Plc
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
and the financial flexibility to realize the full potential of MYCAPSSA® globally and further develop life-cycle management opportunities to expand the benefits … in successfully commercializing MYCAPSSA® globally and expand the potential benefits of MYCAPSSA® to other patients with unmet needs. The combined business
425
k8m njd09bkgtlutlw
5 May 21
Business combination disclosure
5:26pm
F-4
oldwu4fv
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
sdpcnn0n6bq z9i
1 Jul 21
Prospectus supplement
5:20pm
6-K
EX-99.1
cgi7gm5m7g j0j3
5 May 21
Agreement and Plan of Merger
5:19pm
F-4/A
b2ac idmqotlbev92
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
425
xv4icxsl3 b16rp2j
5 May 21
Business combination disclosure
5:27pm
424B3
6i3iuzzu78wd6tb3rql
2 Jun 21
Prospectus supplement
10:09am
424B3
237dvicps
2 Jun 21
Prospectus supplement
10:10am
F-1
EX-10.1
xdgqd1973c xtep95
23 Jun 20
Registration statement (foreign)
5:21pm
6-K
EX-99.1
i5jjw57pu
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
6-K
s3bppbdcc83gbqf
5 May 21
Agreement and Plan of Merger
5:19pm
F-1/A
EX-10.14
38eghk0mox1 ds
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
425
4iw0k wh9lz9om
28 Jul 21
Business combination disclosure
4:56pm
6-K
yyy0kvpr40p6o 5yq1r
5 Aug 21
Appoints Raj Kannan and Dr. Roni Mamluk as Non-Executive Directors
5:17pm
20-F
fpl1uqoo t50n3
30 Apr 21
Annual report (foreign)
12:53pm